Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse

Circulation

Volumn 98, Issue 13, 1998, Pages 1291-1296

  Huggins, Gordon S ^a   Pasternak, Richard C ^a   Alpert, Nathaniel M ^a   Fischman, Alan J ^a   Gewirtz, Henry ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Blood flow; Heart diseases; Ischemia; Simvastatin

Indexed keywords

ADENOSINE; AMMONIA; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NITROGEN 13; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY BLOOD VESSEL; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HUMAN; HYPERLIPIDEMIA; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SECONDARY PREVENTION; VASODILATATION;

EID: 0032578478     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.13.1291     Document Type: Article

References (35)

1. Czernin J, Barnard RJ, Sun KT, Krivokapich J, Nitzsche E, Dorsey D, Phelps ME, Schelbert HR. Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve. Circulation. 1995;92:197-204.
2. Pitkanen OP, Raitakari OT, Niinikoski H, Nuutila P, Iida H, VoipioPulkki LM, Harkonen R, Wegelius U, Ronnemaa T, Viikari J, Knuuti J. Coronary flow reserve is impaired in youag men with familial hypercholesterolemia. J Am Coll Cardiol. 1996;28:1705-1711.
3. Yokoyama I, Ohtake T, Momamura S-i, Nishikawa J, Sasaki Y, Omata M. Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis. Circulation. 1996;94:3232-3238.
4. Dayanikli F, Grambow D, Muzik O, Mosca L, Rubenfire M, Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation. 1994;90:808-817.
5. Gould KL, Martucci JP, Goldberg DI, Hess MJ, Edens RP, Latifi R, Dudrick SJ. Short-term cholesterol lowering decreases size and seventy of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. Circulation. 1994;89: 1530-1538.
6. Schuler G, Hambrecht R, Schlierf G, Grunze M, Methfessel S, Hauer K, Kubler W. Myocardial perfusion and regression of coronary artery disease in patients on a regimen of intensive physical exercise and low fat diet. J Am Coll Cardiol. 1992;19:34-42.
7. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium- dependent coronary vasomotion. N Engl J Med. 1995;332:488-493.
8. Anderson TJ, Meredith IT, Charbonneau F, Yeung AC, Frei B, Selwyn AP, Ganz P. Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. Circulation. 1996;93: 1647-1650.
9. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. Beneficial effects of cholesterol-lowering on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 1995;332:481-487.
10. Gould KL, Ornish D, Kirkeeide R, Brown S, Stuart Y, Buchi M, Billings J, Armstrong W, Ports T, Scherwitz L. Improved stenosis geometry by quantitative coronary arteriography after vigorous risk factor modification. Am J Cardiol. 1992;69:845-853.
11. Friedwald W, Levy R, Fredrickson D. Estimation of the concentration of low-density lipoprotein in plasma, without the use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
12. Gewirtz H, Skopicki HA, Abraham SA, Castano H, Dinsmore RE, Alpert NA, Fischman AJ. Quantitative PET measurements of regional myocardial blood flow: observations in humans with ischemic heart disease. Cardiology. 1997;88:62-70.
13. Skopicki HA, Abraham SA, Weissman NJ, Mukerjee AK, Alpert NA, Fischman AJ, Picard MH, Gewirtz H. Factors influencing regional myocardial contractile response to inotropic stimulation: analysis in humans with stable ischemic heart disease. Circulation. 1996;94:643-650.
14. Skopicki H, Abraham S, Picard M, Alpert N, Fischman A, Gewirtz H. Effects of dobutamine at maximally tolerated dose on myocardial blood flow in humans with ischemic heart disease. Circulation. 1997;96: 3346-3352.
15. Brown BG, Zhao XQ, Sacco DE, Albers JJ. Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary artery disease. Circulation. 1993;87:1781-1791.
16. Superko HR, Krauss RM. Coronary artery disease regression. Circulation. 1994;90:1056-1069.
17. Waters D, Higginson L, Gladstone P, Kimball B, Le May M, Boccuzzi SJ, Lesperance J. Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. Circulation. 1994;89:959-968.
18. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol. 1986;250- H1145-H1149.
19. Vanhoutte PM, Shimokawa H. Endothelium-derived relaxing factor and coronary vasospasm. Circulation. 1989;80:1-9.
20. Demer LL, Gould KL, Goldstein RA, Kirkeeide RL, Mullani NA, Smalling RW, Nishikawa A, Merhige ME. Assessment of coronary artery disease severity by positron emission tomography. Circulation. 1989;79: 825-835.
21. Di Carli M, Czernin J, Hoh CK, Gerbaudo VH, Brunken RC, Huang S-C, Phelps ME, Scheiben HR. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation. 1995;91:1944-1951.
22. Uren NG, Melin JA, De Bruyne B, Wijns W, Baudhuin T, Camici PG. Relation between myocardial blood flow and the severity of coronary artery stenosis. N Engl J Med. 1994;330:1782-1788.
23. Sun Y, Gewirtz H. Estimation of intramyocardial pressure and coronary flow distribution. Am J Physiol (Heart Circ Physiol 24). 1988;255: H664-H672.
24. Uren NG, Marraccini P, Gistri R, de Silva R, Caimici P. Altered coronary vasodilator reserve and metabolism in myocardium subtended by normal arteries in patients with coronary artery disease. J Am Coll Cordiol. 1993;22:650-658.
25. Recchia FA, Senzaki H, Saeki A, Byrne BJ, Kass DA. Pulse pressure- related changes in coronary flow in vivo are modulated by nitric oxide and adenosine. Circ Res. 1996;79:849-856.
26. Davies P. Flow-mediated endocardial mechanotransduction. Physiol Rev. 1995;75:519-560.
27. Canty JM, Schwartz JS. Nitric oxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs. Circulation. 1994;89:375-384.
28. Abebe W, Makujina SR, Mustafa SJ. Adenosine receptor-mediated relaxation of porcine coronary artery in presence and absence of endothelium. Am J Physiol. 1994;266:H2018-H2025.
29. Abebe W, Hussain T, Olanrewaju H, Mustafa SJ. Role of nitric oxide in adenosine receptor-mediated relaxation of porcine coronary artery. Am J Physiol. 1995;269:H1672-H1678.
30. Smits P, Williams SB, Lipson DE, Banitt P, Rongen GA, Creager MA. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation. 1995;92:2135-2141.
31. Fedele FA, Sharaf B, Most AS, Gewirtz H. Details of stenosis morphology influence its hemodynamic severity and distal flow reserve. Circulation. 1989;80:636-642.
32. Rossen JD, Simonetti I, Marcus ML, Winniford MD. Coronary dilation with standard dose dipyridamole and dipyridamole combined with handgrip. Circulation. 1989;79:566-572.
33. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD. Effects of adenosine on human coronary arterial circulation. Circulation. 1990; 1990:1595-1606.
34. Group SSSS. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study Group (4S). Lancet. 1994;344:1383-1389.
35. Andrews TC, Raby K, Barry J, Naimi CL, Allred E, Ganz P, Selwyn AP. Effect of cholesterol reduction on myocardial ischemia in patients with coronary artery disease. Circulation. 1997;95:324-328.